We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares

Delisted

AMYT was delisted on the 11th of April, 2023.

65 hedge funds and large institutions have $379M invested in Amryt Pharma plc American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

775% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 4

600% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 2

111% more capital invested

Capital invested by funds: $180M → $379M (+$199M)

91% more funds holding

Funds holding: 3465 (+31)

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

Holders
65
Holders Change
+31
Holders Change %
+91.18%
% of All Funds
1.14%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
35
Increased
14
Reduced
2
Closed
4
Calls
$202K
Puts
Net Calls
+$202K
Net Calls Change
+$202K

AMYT Hedge Fund Activity: Q3 2021 in Review

65 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q3 2021, worth a combined $379M — up 111% from $180M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMYT positions and 4 closed out — a net gain of 31 holders — while 14 added to existing stakes and 2 trimmed.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $36.8M. The largest seller was Tudor Investment Corp, exiting entirely with an estimated $485K sold.

  • 65 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q3 2021, up from 34 in Q2 2021.
  • Funds reported $379M of Amryt Pharma plc American Depositary Shares stock for Q3 2021, up 111% quarter-over-quarter.
  • 35 funds opened new Amryt Pharma plc American Depositary Shares positions in Q3 2021 and 4 closed out, a net change of +31 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q3 2021 was Rubric Capital Management (New York), an estimated $36.8M added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q3 2021 was Tudor Investment Corp, an estimated $485K sold.

Based on aggregated 13F filings for Q3 2021.